Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 132 (RN7SKP132) is classified as a pseudogene in the human genome, related to the RN7SK gene encoding 7SK small nuclear RNA[3]. Unlike RN7SK, which has important biological functions in controlling transcriptional elongation by RNA polymerase II and is a critical regulator within the 7SK ribonucleoprotein complex[1][2][4][5], RN7SKP132 is not known to encode a functional RNA or protein, has no established biological functions or disease associations, and is not considered druggable or a therapeutic target in current biomedical literature[3]. Any reference to RN7SKP132 as a therapeutic target would be incorrect; focus should shift to RN7SK, the functional small nuclear RNA. If structured information is sought about the functional molecule (RN7SK), refer to RN7SK (RNA component of 7SK nuclear ribonucleoprotein), which has defined roles in transcription regulation and disease association[1][2][4][5]. Otherwise, for RN7SKP132, the above details reflect its pseudogene status and lack of clinical or biological targeting utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 132 (RN7SKP132).